Industry News
IBS patients scramble to find alternative treatments for relief as FDA pulls IBS drug Zelnorm from market - *Quantum Focusing®, self-directed program of self-hypnosis exercises, alleviates IBS symptoms safely & affordably without drugs or surgery
April 4, 2007
IBS patients, previously dependent on the drug Zelnorm for relief from symptoms experienced with Irritable Bowel Syndrome, will find hope, and help, in a system of self-hypnosis exercises developed and tested by Medical Hypnosis Educators Michael Ellner and Alan Barsky called Quantum Focusing®. Story
New online interactive knowledge centre on the treatment of neuropathic pain
April 3, 2007
IMR International Limited, developers of e-communication and clinical information solutions, today announced that Pfizer will partner with the Company to develop a new online interactive knowledge centre on the treatment of Neuropathic Pain. Story
Pfizer to resume airing ads for Celebrex
April 2, 2007
Pfizer (PFE) plans to launch a 2½-minute TV commercial Monday for arthritis painkiller Celebrex, which has been off TV for more than two years due to safety concerns about drugs in its class. The spot is five times as long as most TV ads. Pfizer says the time is needed to explain Celebrex's risks and benefits and to dispel confusion. Story
Purdue Pharma L.P. announces agreement to end OxyContin(R) patent lawsuit with IMPAX Laboratories
April 2, 2007
Under the terms of the settlement agreement, IMPAX Laboratories acknowledges that Purdue Pharma's OxyContin patents are valid, enforceable and infringed by IMPAX's extended-release oxycodone products and Purdue agrees it will not pursue damages against IMPAX for past infringement. Purdue also will grant a license to permit IMPAX (through its marketing partner, DAVA Pharmaceuticals) to keep its extended- release oxycodone products on the market through June 14, 2007 Story
Patients, Physicians, and Pharmacists Fighting Diversion Organization selects ImageWare Systems to help combat prescription narcotic drug abuse
April 2, 2007
ImageWare® Systems, Inc. (AMEX:IW), a leading developer of identity management solutions, today announced the company was selected by the non-profit consortium of Patients, Physicians, and Pharmacists Fighting Diversion (PPPFD™) to implement a comprehensive biometric identity management solution as part of its Forensic Medicine Technology™ program. The purpose of this system is to fight prescription narcotic drug abuse and diversion while ensuring law abiding patients continue to have access to the narcotic medicines they need. Email Story
Neck buzzer that can soothe migraines
March 27, 2007
Migraines and painful cluster headaches could be eased by stimulating nerves at the back of the neck. The technique - where wires carrying electrical impulses are implanted in the neck - is being tested in a number of clinical trials. Story
Ivivi PEMF technology provides a non-pharmacologic approach for AHA guidelines to avoid NSAIDs for patients at risk for heart disease
March 22, 2007
Great strides have been made over the past several years in elucidating the mechanisms of action of pulsed electromagnetic field, or PEMF. This technology, which creates non-thermal electrical current in injured soft tissue, is specifically configured to augment the biochemical and physiological processes used by the human body to reduce pain and edema in its natural quest for tissue repair. Story
Ivivi PEMF technology provides a non-pharmacologic approach for AHA guidelines to avoid NSAIDs for patients at risk for heart disease
March 22, 2007
Great strides have been made over the past several years in elucidating the mechanisms of action of pulsed electromagnetic field, or PEMF. This technology, which creates non-thermal electrical current in injured soft tissue, is specifically configured to augment the biochemical and physiological processes used by the human body to reduce pain and edema in its natural quest for tissue repair. Story
Studies demonstrate Synera patch can provide patients significant relief from the pain association with venous access procedures
March 21, 2007
Endo Pharmaceuticals Inc. today presented results from four clinical studies evaluating the efficacy and safety of its Synera topical patch, a peel-and-stick anesthetic patch with a novel heating technology. Synera™ is indicated for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures. Story
New web site promotes Infratonic therapy for pain relief, reduced inflammation, and advanced healing
March 21, 2007
The site, found at www.soundvitality.com, offers scientific research, an online store for Infratonic therapeutic massagers, specific treatment solutions for a wide range of medical conditions, and inspiring testimonials from numerous patients who have experienced first-hand relief from their painful or chronic ailments. Story
Wockhardt to market painkiller tablets in US market
March 19, 2007
Algodyne is targeting pain measurement with a proprietary gauge designed to objectively quantify pain. Story
Chiropractors and physical therapists getting new pain treatment;
MyoMed, an all-natural analgesic and anti-inflammatory cream, released soon
March 13, 2007
Along with regular adjustments and physical therapy, all-natural pain relief relies on creams that often use menthol for instant relief without lasting effects. These creams fail to penetrate deep enough into sore tissues to provide therapeutic healing. BioForce, a health products company, an-nounces the pending release of MyoMed (myo-med.com). MyoMed, coming soon, relies on cetylated fatty acids, other proven homeopathic ingredients, and a unique nano-delivery system to relieve pain and reduce inflammation deep inside dermal tissues. Story
Introducing new ALEVE® Liquid Gels
March 13, 2007
Bayer Consumer Care announces the introduction of ALEVE® Liquid Gels, combining the all-day pain relieving power of ALEVE (naproxen sodium) with “liquid-fast” speed and convenient dosing for those who suffer from back and joint pain. Story
GenoMed prevents sickle cell pain for over a year
March 12, 2007
GenoMed announced today publication of a case report of a sickle cell patient whose pain has disappeared for over a year thanks to GenoMed's treatment. Story
|
